4//SEC Filing
Choong Ingrid 4
Accession 0000905148-23-000841
CIK 0001305253other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 9:38 PM ET
Size
5.1 KB
Accession
0000905148-23-000841
Insider Transaction Report
Form 4
Choong Ingrid
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-08-31+54,000→ 54,000 totalExercise: $0.86Exp: 2033-08-30→ Common Stock (54,000 underlying)
Footnotes (1)
- [F1]The option vests in equal installments over 48 months measured from August 31, 2023, subject to the Reporting Person's continuous service as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001991912
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 9:38 PM ET
- Size
- 5.1 KB